Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Leslie Citrome, Anna Eramo, Clement Francois, Ruth Duffy, Susan N Legacy, Steve J Offord, Holly B Krasa, Stephen S Johnston, Alice Guiraud-Diawara, Siddhesh A Kamat & Patricia Rohman. (2015) Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 3095-3104.
Read now
Read now
Articles from other publishers (37)
Maria Angelaki, Eirini Alexiou, Artemis Igoumenou & Giorgos Alevizopoulos. (2023) Frequency of sexual dysfunction in outpatients with severe mental illness in Greece. Frontiers in Psychiatry 14.
Crossref
Crossref
E. G. Poltavskaya, V. V. Tiguntsev, A. S. Boiko, E. G. Kornetova, S. A. Ivanova & O. Yu. Fedorenko. (2023) Study of Associations of the GRM8 Gene with Antipsychoticinduced Hyperprolactinemia. Personalized Psychiatry and Neurology 3:1, pages 42-47.
Crossref
Crossref
Marco Solmi, Markku Lähteenvuo, Christoph U Correll, Antti Tanskanen, Jari Tiihonen & Heidi Taipale. (2023) Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland. Schizophrenia Bulletin 49:1, pages 78-89.
Crossref
Crossref
Sabrina Meyer Krøigaard, Lars ClemmensenSimon TarpAnne Katrine Pagsberg. (2022) A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology 32:7, pages 374-389.
Crossref
Crossref
Gema Martínez‐Giner, Elisa Giménez‐De Llano, Dolores Romero‐Rubio, María José Abad‐Pérez & Vanessa Sánchez‐Martínez. (2022) Sexual dysfunction in people treated with long‐acting injectable antipsychotics in monotherapy or polypharmacy: a naturalistic study. International Journal of Mental Health Nursing 31:3, pages 576-590.
Crossref
Crossref
E. Limoncin, G. Ciocca, G. Castellini, A. Sansone, F. Cavalieri, F. Cavallo, T. Cocchiaro, V. Ricca, G. di Lorenzo, A. Rossi, A. D. Fisher, V. Rochira, G. Corona & E. A. Jannini. (2022) Hypersexuality as a tip of the iceberg of a primary psychopathology: a joined position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) and of the Italian Society of Psychopathology (SOPSI). Journal of Endocrinological Investigation 45:9, pages 1787-1799.
Crossref
Crossref
Wang Zhenhua, Chen Haizhi, Li Jing, Fei Xiaocong, Li Jianhua, Liu Jianjun, Lei Lilei & Jin Haiying. (2021) Occurrence of macroprolactinemia in schizophrenia patients treated with risperidone or amisulpride. Asia-Pacific Psychiatry 14:1.
Crossref
Crossref
Bodyl A. Brand, Yudith R. A. Haveman, Franciska de Beer, Janna N. de Boer, Paola Dazzan & Iris E. C. Sommer. (2021) Antipsychotic medication for women with schizophrenia spectrum disorders. Psychological Medicine 52:4, pages 649-663.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
1
224
.
Tzu-Hua Wu, Chieh-Hsin Lin, Kah Kheng Goh, Cynthia Yi-An Chen, Chun-Hsin Chen, Hsien-Yuan Lane & Mong-Liang Lu. (2021) The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment. Frontiers in Pharmacology 12.
Crossref
Crossref
Bodyl A. Brand, Janna N. de Boer & Iris E.C. Sommer. (2021) Estrogens in schizophrenia: progress, current challenges and opportunities. Current Opinion in Psychiatry 34:3, pages 228-237.
Crossref
Crossref
Angel L. Montejo, Rubén de Alarcón, Nieves Prieto, José Mª Acosta, Bárbara Buch & Laura Montejo. (2021) Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach. Journal of Clinical Medicine 10:2, pages 308.
Crossref
Crossref
Karen Romain, Sarah Fynes-Clinton, David Harmer & Manoj Kumar. (2020) Hyperprolactinaemia in the context of psychiatry. BJPsych Advances 27:1, pages 26-37.
Crossref
Crossref
Ahmed A. Moustafa, Belinda Favaloro, Doaa H. Hewedi, Nagla N. El Mahallawy & Hossam ElKhatib. 2021. Cognitive and Behavioral Dysfunction in Schizophrenia. Cognitive and Behavioral Dysfunction in Schizophrenia
127
140
.
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov & Graham Meadows. (2020) Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia. CNS Drugs 34:5, pages 473-507.
Crossref
Crossref
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck & Alison R Yung. (2019) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 34:1, pages 3-78.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Joseph R. Calabrese, Na Jin, Brian Johnson, Pedro Such, Ross A. Baker, Jessica Madera, Peter Hertel, Jocelyn Ottinger, Joan Amatniek & Hiroaki Kawasaki. (2018) Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. International Journal of Bipolar Disorders 6:1.
Crossref
Crossref
Joseph R. Calabrese, Raymond Sanchez, Na Jin, Joan Amatniek, Kevin Cox, Brian Johnson, Pamela P. Perry, Peter Hertel, Pedro Such, Robert D. McQuade, Margaretta Nyilas & William H. Carson. (2018) The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of Affective Disorders 241, pages 425-432.
Crossref
Crossref
A. Marcuz, C. Thevenon, A. Amariei, S. Duhem & C-L. Charrel. (2018) Troubles psychotiques et sexualité. French Journal of Psychiatry 1, pages S143.
Crossref
Crossref
Angel L. Montejo, Laura Montejo & David S. Baldwin. (2018) The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry 17:1, pages 3-11.
Crossref
Crossref
Marc De Hert & Johan Detraux. 2018. Sexual Dysfunctions in Mentally Ill Patients. Sexual Dysfunctions in Mentally Ill Patients
83
97
.
Baptiste Pignon, Chloé Tezenas du Montcel, Louise Carton & Antoine Pelissolo. (2017) The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Current Psychiatry Reports 19:12.
Crossref
Crossref
Steven G. Potkin, Jean-Yves Loze, Carlos Forray, Ross A. Baker, Christophe Sapin, Timothy Peters-Strickland, Maud Beillat, Anna-Greta Nylander, Peter Hertel, Henrik Steen Andersen, Anna Eramo, Karina Hansen & Dieter Naber. (2017) Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate. International Clinical Psychopharmacology 32:3, pages 147-154.
Crossref
Crossref
Leila Jahangard, Shahrokh Akbarian, Mohammad Haghighi, Mohammad Ahmadpanah, Amir Keshavarzi, Hafez Bajoghli, Dena Sadeghi Bahmani, Edith Holsboer-Trachsler & Serge Brand. (2017) Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial. Psychiatry Research 251, pages 182-191.
Crossref
Crossref
Mohanalakshmi M, Alexander Gnana Durai W.J, Kalaimathi B, Nileena N. K. M, Punithavathi D, Gayathri K & Saravana Jothi R. (2017) SEXUAL DYSFUNCTION INDUCED BY ANTI-PSYCHOTICS AND ANTI-DEPRESSANTS IN DRUG NAIVE PATIENTS – A COMPARATIVE STUDY. Journal of Evidence Based Medicine and Healthcare 4:24, pages 1414-1419.
Crossref
Crossref
Anne Katrine Pagsberg, Simon Tarp, Dorte Glintborg, Anne Dorte Stenstrøm, Anders Fink-Jensen, Christoph Ulrich Correll & Robin Christensen. (2017) Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry 56:3, pages 191-202.
Crossref
Crossref
Elena Rubio-AbadalNúria Del CachoGerard Saenz-NavarreteBelen ArranzRosa-Maria CambraDaniel CuadrasDemián RodanteCsaba FehérMercedes RocaVanessa BarnedaJudith Usall. (2016) How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment. Journal of Clinical Psychopharmacology 36:5, pages 422-428.
Crossref
Crossref
Itaru Miura, Jian-Ping Zhang, Katsuhiko Hagi, Todd Lencz, John M. Kane, Hirooki Yabe, Anil K. Malhotra & Christoph U. Correll. (2016) Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis. Psychoneuroendocrinology 72, pages 1-10.
Crossref
Crossref
Donna Ames, Sian M. Carr-Lopez, Mary A. Gutierrez, Joseph M. Pierre, Jennifer A. Rosen, Susan Shakib & Lynn M. Yudofsky. (2016) Detecting and Managing Adverse Effects of Antipsychotic Medications. Psychiatric Clinics of North America 39:2, pages 275-311.
Crossref
Crossref
Young-Min Park, Seung-Hwan Lee, Bun-Hee Lee, Kyu Young Lee, Kye-Seong Lee, Seung-Gul Kang, Hwa-Young Lee & Won Kim. (2016) Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study. Psychiatry Research 239, pages 184-189.
Crossref
Crossref
Angel L. Montejo, Laura Montejo & Felipe Navarro-Cremades. (2015) Sexual side-effects of antidepressant and antipsychotic drugs. Current Opinion in Psychiatry 28:6, pages 418-423.
Crossref
Crossref
Antonio Ventriglio, Alessandro Gentile, Eleonora Stella & Antonello Bellomo. (2015) Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management. Frontiers in Neuroscience 9.
Crossref
Crossref
Isabella Pacchiarotti, Andrea Murru, Georgios D. Kotzalidis, C. Mar Bonnin, Lorenzo Mazzarini, Francesc Colom & Eduard Vieta. (2015) Hyperprolactinemia and medications for bipolar disorder: Systematic review of a neglected issue in clinical practice. European Neuropsychopharmacology 25:8, pages 1045-1059.
Crossref
Crossref
Brigitta E. Miyamoto, Martha Galecki & Dimitry Francois. (2015) Guidelines for Antipsychotic-Induced Hyperprolactinemia. Psychiatric Annals 45:5, pages 266-272.
Crossref
Crossref
Antonio Ventriglio, Antonello Bellomo & Dinesh Bhugra. 2015. International Encyclopedia of the Social & Behavioral Sciences. International Encyclopedia of the Social & Behavioral Sciences
21
27
.
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Crossref